BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
View ORCID ProfileKsenija Nesic, View ORCID ProfileJohn J. Krais, Cassandra J. Vandenberg, Yifan Wang, Pooja Patel, Kathy Q. Cai, Tanya Kwan, Elizabeth Lieschke, Gwo-Yaw Ho, Holly E. Barker, Justin Bedo, Silvia Casadei, Andrew Farrell, Marc Radke, Kristy Shield-Artin, Jocelyn S. Penington, Franziska Geissler, Elizabeth Kyran, Fan Zhang, Alexander Dobrovic, Inger Olesen, Rebecca Kristeleit, Amit Oza, Gayanie Ratnayake, Nadia Traficante, Australian Ovarian Cancer Study, Anna DeFazio, David D. L. Bowtell, Thomas C. Harding, Kevin Lin, Elizabeth M. Swisher, Olga Kondrashova, Clare L. Scott, Neil Johnson, Matthew J. Wakefield
doi: https://doi.org/10.1101/2023.03.20.23287465
Ksenija Nesic
1The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
2Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
John J. Krais
3Fox Chase Cancer Center, PA, USA
Cassandra J. Vandenberg
1The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
2Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
Yifan Wang
3Fox Chase Cancer Center, PA, USA
Pooja Patel
3Fox Chase Cancer Center, PA, USA
Kathy Q. Cai
3Fox Chase Cancer Center, PA, USA
Tanya Kwan
4Clovis Oncology Inc., San Francisco, CA, USA
Elizabeth Lieschke
1The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
2Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
Gwo-Yaw Ho
5School of Clinical Sciences, Monash University, Clayton, Victoria, Australia
Holly E. Barker
1The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
2Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
Justin Bedo
1The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
2Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
Silvia Casadei
6University of Washington, Seattle, WA, USA
Andrew Farrell
1The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
2Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
Marc Radke
6University of Washington, Seattle, WA, USA
Kristy Shield-Artin
1The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
2Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
Jocelyn S. Penington
1The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
2Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
Franziska Geissler
1The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
2Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
Elizabeth Kyran
1The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
2Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
Fan Zhang
7University of Melbourne Department of Surgery, Austin Health, Heidelberg, Victoria, Australia
Alexander Dobrovic
7University of Melbourne Department of Surgery, Austin Health, Heidelberg, Victoria, Australia
Inger Olesen
8The Andrew Love Cancer Centre, Barwon Health, Geelong, Victoria, Australia
Rebecca Kristeleit
9Department of Oncology, Guys and St Thomas’ NHS Foundation Trust, London, UK
10National Institute for Health Research, University College London Hospitals Clinical Research Facility, London, UK
Amit Oza
11Princess Margaret Cancer Center, Toronto, ON, Canada
Gayanie Ratnayake
12Royal Women’s Hospital, Parkville, VIC, Australia
Nadia Traficante
13Sir Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
14Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
Anna DeFazio
15The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council New South Wales, Sydney, New South Wales, Australia
16The Westmead Institute for Medical Research, Sydney, New South Wales, Australia
17Department of Gynecological Oncology, Westmead Hospital, Western Sydney Local Health District, New South Wales, Australia
David D. L. Bowtell
13Sir Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
14Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
Thomas C. Harding
4Clovis Oncology Inc., San Francisco, CA, USA
Kevin Lin
4Clovis Oncology Inc., San Francisco, CA, USA
Elizabeth M. Swisher
6University of Washington, Seattle, WA, USA
Olga Kondrashova
18QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
Clare L. Scott
1The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
2Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
12Royal Women’s Hospital, Parkville, VIC, Australia
13Sir Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
14Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
19Department of Obstetrics and Gynecology, University of Melbourne, Parkville, VIC, Australia
Neil Johnson
3Fox Chase Cancer Center, PA, USA
Matthew J. Wakefield
1The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
2Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
19Department of Obstetrics and Gynecology, University of Melbourne, Parkville, VIC, Australia
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted August 28, 2023.
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
Ksenija Nesic, John J. Krais, Cassandra J. Vandenberg, Yifan Wang, Pooja Patel, Kathy Q. Cai, Tanya Kwan, Elizabeth Lieschke, Gwo-Yaw Ho, Holly E. Barker, Justin Bedo, Silvia Casadei, Andrew Farrell, Marc Radke, Kristy Shield-Artin, Jocelyn S. Penington, Franziska Geissler, Elizabeth Kyran, Fan Zhang, Alexander Dobrovic, Inger Olesen, Rebecca Kristeleit, Amit Oza, Gayanie Ratnayake, Nadia Traficante, Australian Ovarian Cancer Study, Anna DeFazio, David D. L. Bowtell, Thomas C. Harding, Kevin Lin, Elizabeth M. Swisher, Olga Kondrashova, Clare L. Scott, Neil Johnson, Matthew J. Wakefield
medRxiv 2023.03.20.23287465; doi: https://doi.org/10.1101/2023.03.20.23287465
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
Ksenija Nesic, John J. Krais, Cassandra J. Vandenberg, Yifan Wang, Pooja Patel, Kathy Q. Cai, Tanya Kwan, Elizabeth Lieschke, Gwo-Yaw Ho, Holly E. Barker, Justin Bedo, Silvia Casadei, Andrew Farrell, Marc Radke, Kristy Shield-Artin, Jocelyn S. Penington, Franziska Geissler, Elizabeth Kyran, Fan Zhang, Alexander Dobrovic, Inger Olesen, Rebecca Kristeleit, Amit Oza, Gayanie Ratnayake, Nadia Traficante, Australian Ovarian Cancer Study, Anna DeFazio, David D. L. Bowtell, Thomas C. Harding, Kevin Lin, Elizabeth M. Swisher, Olga Kondrashova, Clare L. Scott, Neil Johnson, Matthew J. Wakefield
medRxiv 2023.03.20.23287465; doi: https://doi.org/10.1101/2023.03.20.23287465
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)